What is the address of PHARMACOACH?

The registered office of PHARMACOACH is located at Rue de l'Eglise 48, 7950 Chièvres.

Is PHARMACOACH still active?

Yes. According to the CBE (30 October 2026) PHARMACOACH is active, legal situation “Normale toestand”, started on 29 December 2015.

Is PHARMACOACH registered on Peppol?

Yes, PHARMACOACH is registered on the Peppol network with ID 0208:0644955374.

What is the enterprise number of PHARMACOACH?

The enterprise number of PHARMACOACH is BE0644955374.

When was PHARMACOACH founded?

PHARMACOACH was founded on 29 December 2015.

Who are the directors of PHARMACOACH?

According to the 2025 annual accounts, the directors of PHARMACOACH are: PAUL RANSART.

Is PHARMACOACH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 December 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACOACH make in 2025?

PHARMACOACH posted a profit after taxes of € 22,487 in financial year 2025.

What is the revenue of PHARMACOACH?

As a small company, PHARMACOACH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 233,188.

How much does an employee at PHARMACOACH earn?

The average wage cost per full-time employee at PHARMACOACH was € 67,200 in 2022: staff costs of € 181,324 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACOACH (Private Limited) - Chièvres - BE0644955374

Q: What does PHARMACOACH do?

PHARMACOACH is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 29 December 2015, 1 establishment.

Dossier PHARMACOACH, printed on 30 October 2026 from databakkes.be/en/0644955374/pharmacoach. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACOACH from Chièvres, company number BE0644955374, closed financial year 2025 with a result of € 22,487 after tax. For that financial year PHARMACOACH recorded a gross margin of € 233,188 and equity of € 172,482. Compared with financial year 2024, the result moved from € 11,407 to € 22,487. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Healthy

€ 172,482

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,487

▲ 97% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 49,828

▲ € 49,749 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 182,511

▼ 7% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,686

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 32 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 283,965

▼ 4% vs 2024

€ 8,860 is repaid this year. At this pace the long-term loan is gone in ≈ 32 years.

Owed to suppliers

€ 44,089

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 47,776

▲ 27% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 277,401 Gross margin 2022: € 277,401 First fiscal year in the series	€ 261,966 Gross margin 2023: € 261,966 ▼ 6% vs 2022 (€ 277,401) Unfavourable step	€ 242,742 Gross margin 2024: € 242,742 ▼ 7% vs 2023 (€ 261,966) Unfavourable step	€ 233,188 Gross margin 2025: € 233,188 ▼ 4% vs 2024 (€ 242,742) Unfavourable step	▼ 4%
Profit after taxes	€ 60,363 Profit after taxes 2022: € 60,363 First fiscal year in the series	€ 35,775 Profit after taxes 2023: € 35,775 ▼ 41% vs 2022 (€ 60,363) Unfavourable step	€ 11,407 Profit after taxes 2024: € 11,407 ▼ 68% vs 2023 (€ 35,775) Unfavourable step	€ 22,487 Profit after taxes 2025: € 22,487 ▲ 97% vs 2024 (€ 11,407) Favourable step	▲ 97%
Equity	€ 132,814 Equity 2022: € 132,814 First fiscal year in the series	€ 168,588 Equity 2023: € 168,588 ▲ 27% vs 2022 (€ 132,814) Favourable step	€ 179,995 Equity 2024: € 179,995 ▲ 7% vs 2023 (€ 168,588) Favourable step	€ 172,482 Equity 2025: € 172,482 ▼ 4% vs 2024 (€ 179,995) Unfavourable step	▼ 4%
Total debts	€ 120,248 Total debts 2022: € 120,248 First fiscal year in the series	€ 407,240 Total debts 2023: € 407,240 ▲ 239% vs 2022 (€ 120,248) Unfavourable step	€ 399,342 Total debts 2024: € 399,342 ▼ 2% vs 2023 (€ 407,240) Favourable step	€ 428,661 Total debts 2025: € 428,661 ▲ 7% vs 2024 (€ 399,342) Unfavourable step	▲ 7%
Cash	€ 7,860 Cash 2022: € 7,860 First fiscal year in the series	€ 735 Cash 2023: € 735 ▼ 91% vs 2022 (€ 7,860) Unfavourable step	€ 79 Cash 2024: € 79 ▼ 89% vs 2023 (€ 735) Unfavourable step	€ 49,828 Cash 2025: € 49,828 ▲ € 49,749 vs 2024 (€ 79) Favourable step	▲ € 49,749
Land & buildings	-	€ 41,282 Land & buildings 2023: € 41,282 First fiscal year in the series	€ 41,282 Land & buildings 2024: € 41,282 Unchanged (€ 41,282) Unchanged	€ 41,282 Land & buildings 2025: € 41,282 Unchanged (€ 41,282) Unchanged
Retained profit	€ 114,214 Retained profit 2022: € 114,214 First fiscal year in the series	€ 149,988 Retained profit 2023: € 149,988 ▲ 31% vs 2022 (€ 114,214) Favourable step	€ 161,395 Retained profit 2024: € 161,395 ▲ 8% vs 2023 (€ 149,988) Favourable step	€ 153,882 Retained profit 2025: € 153,882 ▼ 5% vs 2024 (€ 161,395) Unfavourable step	▼ 5%
Dividend	€ 11,000 Dividend 2022: € 11,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 11,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 30,000 Dividend 2025: € 30,000 Unchanged (€ 0) Unchanged
Bank debt	€ 18,673 Bank debt 2022: € 18,673 First fiscal year in the series	€ 310,366 Bank debt 2023: € 310,366 ▲ € 291,693 vs 2022 (€ 18,673) Unfavourable step	€ 295,275 Bank debt 2024: € 295,275 ▼ 5% vs 2023 (€ 310,366) Favourable step	€ 283,965 Bank debt 2025: € 283,965 ▼ 4% vs 2024 (€ 295,275) Favourable step	▼ 4%
Balance sheet total	€ 253,061 Balance sheet total 2022: € 253,061 First fiscal year in the series	€ 575,829 Balance sheet total 2023: € 575,829 ▲ 128% vs 2022 (€ 253,061) Unchanged	€ 579,337 Balance sheet total 2024: € 579,337 ▲ 1% vs 2023 (€ 575,829) Unchanged	€ 601,143 Balance sheet total 2025: € 601,143 ▲ 4% vs 2024 (€ 579,337) Unchanged	▲ 4%
Employees (FTE)	2.7 Employees (FTE) 2022: 2.7 First fiscal year in the series	-	-	-

Key figures of PHARMACOACH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to PHARMACOACH?

What happened at PHARMACOACH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 22,487 (▲ 97% vs 2024). Source: NBB ↗
Dec 29, 2015 New establishment in Chièvres. KBO
2015 PAUL RANSART became a director. NBB
Dec 29, 2015 Start of the company according to the CBE. KBO

In short

From € 60,363 profit in 2022 to € 22,487 profit in 2025.

Paid € 72,448 in corporate taxes since 2022.

Best year ever: 2022, with € 60,363 profit.

On average € 102,700 of value added per employee in 2022.

Original PDFs at the National Bank ↗

Management

PAUL RANSART

PHARMACOACH

COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE

PHARMACIE de BARRY

PALATINE

+20

Behind PHARMACOACH is PAUL RANSART. PAUL RANSART is also behind COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS and IMMOLENANS.

Directors

According to the 2025 annual accounts

PAUL RANSART

Manager

Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, APOGREZ, ANCIAUX, LES PHARMACIES RURALES +15 more

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de l'Eglise 48

7950 Chièvres

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

PHARMADVANCE same network

€ 299,297 gross margin · 2025

ASKELA

€ 25,341 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0644.955.374

VAT number

BE 0644.955.374

Registered office

Rue de l'Eglise 48, 7950 Chièvres

Names & denominations

PHARMACOACH

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 December 2015

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige technische testen en toetsen

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACOACH

Financials

What happened to PHARMACOACH?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions